Statins Plus Metformin: a Promising Combination for Prevention and Treatment of Atherosclerosis

Fei Luo, Yuan Guo, Xiang-ping Li

Abstract


Statins are the cornerstone for primary and secondary prevention of atherosclerosis. But statin monotherapy in some patients will not be sufficient to achieve an LDL-C target and increase the incidence of new-onset diabetes in a dose dependent manner, especially in women, elderly, presence of family history of type 2 diabetes and Asian ethnicity. Recently metformin, an old and effective antidiabetic medication, has been found to reduce LDL-C levels and has cardiac benefits for patients with T2D. Therefore, statins plus metformin may further reduce LDL-C levels and partly counteract statin-induced diabetes.


Full Text:

PDF

References


Ruscica M, Macchi C, Morlotti B, Sirtori CR, Magni P. Statin therapy and related risk of new-onset type 2 diabetes mellitus. Eur J Intern Med. 2014;25(5):401-6. doi:10.1016/j.ejim.2014.03.003.

Catapano AL, Farnier M, Foody JM, Toth PP, Tomassini JE, Brudi P et al. Combination therapy in dyslipidemia: where are we now? Atherosclerosis. 2014;237(1):319-35. doi:10.1016/j.atherosclerosis.2014.09.026.

Burla AK, Lobato NS, Fortes ZB, Oigman W, Neves MF. Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats. Int J Cardiol. 2013;165(3):483-7. doi:10.1016/j.ijcard.2011.09.012.

Romero SP, Andrey JL, Garcia-Egido A, Escobar MA, Perez V, Corzo R et al. Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community. Int J Cardiol. 2013;166(2):404-12. doi:10.1016/j.ijcard.2011.10.141.

Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC, Jr., Goto S et al. Metformin use and mortality among patients with diabetes and atherothrombosis. JAMA Intern Med. 2010;170(21):1892-9. doi:10.1001/archinternmed.2010.409.

Xu T, Brandmaier S, Messias AC, Herder C, Draisma HH, Demirkan A et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care. 2015;38(10):1858-67 doi:10.2337/dc15-0658.

Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism. 2001;50(7):856-61. doi:10.1053/meta.2001.24192.

Sone Y, Kido T, Ainuki T, Sonoda M, Ichi I, Kodama S et al. Genetic variants of the fatty acid desaturase gene cluster are associated with plasma LDL cholesterol levels in Japanese males. J Nutr Sci Vitaminol (Tokyo). 2013;59(4):325-35.

Nakata M, Nagasaka S, Kusaka I, Matsuoka H, Ishibashi S, Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia. 2006;49(8):1881-92. doi:10.1007/s00125-006-0269-5.

Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001;409(6821):729-33. doi:10.1038/35055575.

Krysiak R, Okopien B. The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose. Metabolism. 2013;62(1):39-43. doi:10.1016/j.metabol.2012.06.009.

Aubdoollah TH, Li K, Zhang X, Li S, Yang L, Lei HY et al. Clinical outcomes and ergonomics analysis of three laparoscopic techniques for Hirschsprung's disease. World J Gastroenterol. 2015;21(29):8903-11. doi:10.3748/wjg.v21.i29.8903.

Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006;116(7):1776-83. doi:10.1172/JCI29044.

Preiss D, Lloyd SM, Ford I, McMurray JJ, Holman RR, Welsh P et al. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2(2):116-24. doi:10.1016/S2213- 8587(13)70152-9.

Shewan L.G., Coats A.J.S., Henein M. Requirements for Ethical Publishing in Biomedical Journals. International Cardiovascular Forum Journal. 2015;2:2. http://dx.doi.org/10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/jatamis.v1i0.332

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Fei Luo, Yuan Guo, Xiang-ping Li

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2518-6140 (on-line version)